Gongshu District

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Mantle cell lymphoma1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Acerta Pharma BV1 trial
• AstraZeneca1 trial

Running trials

• Active, not recruiting

  Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

  NCT04305496· Phase 3· AstraZeneca· Source

• Active, not recruiting

  A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL

  NCT02972840· Phase 3· Acerta Pharma BV· Source